Drugmakers delivered tasty returns to investors in July. Pharmaceutical ETFs topped peers holding broadly diversified health care stocks as well as those focused on red-hot biotechs. (PJP) lags its pharma ETF peers this month despite a 3.6% rise. But it leads year to date with a 22% advance, and over longer periods. It produced an annual average 35% gain over five years vs. 30% for (XPH). The $2.14 billion ETF holds several IBD Sector Leaders in
Thursday 30 July 2015
A Pharma ETF Focused On Quality, Fast-Growing Stocks
Otmane El Rhazi from Investor's Business Daily - ETFs RSS.
Drugmakers delivered tasty returns to investors in July. Pharmaceutical ETFs topped peers holding broadly diversified health care stocks as well as those focused on red-hot biotechs. (PJP) lags its pharma ETF peers this month despite a 3.6% rise. But it leads year to date with a 22% advance, and over longer periods. It produced an annual average 35% gain over five years vs. 30% for (XPH). The $2.14 billion ETF holds several IBD Sector Leaders in
Drugmakers delivered tasty returns to investors in July. Pharmaceutical ETFs topped peers holding broadly diversified health care stocks as well as those focused on red-hot biotechs. (PJP) lags its pharma ETF peers this month despite a 3.6% rise. But it leads year to date with a 22% advance, and over longer periods. It produced an annual average 35% gain over five years vs. 30% for (XPH). The $2.14 billion ETF holds several IBD Sector Leaders in
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment